Literature DB >> 31473582

Overweight in classical phenylketonuria children: A retrospective cohort study.

Dariusz Walkowiak1, Lukasz Kaluzny2, Anna Bukowska-Posadzy3, Mariusz Oltarzewski4, Rafal Staszewski5, Jerzy A Moczko6, Michal Musielak7, Jaroslaw Walkowiak2.   

Abstract

PURPOSE: This cohort study aimed to determine the frequency of overweight and obesity in classical phenylketonuria children and to identify the possible influence of metabolic control on the BMI of the studied patients. PATIENTS AND METHODS: The study group included 63 classical phenylketonuria patients (40 girls and 23 boys; aged 5-16 years). Their z-score BMI, metabolic control, educational level of parents and socioeconomic status were determined.
RESULTS: Twenty children were overweight or obese and only three were underweight. The percentages of overweight and obese children were 31.7% for the whole group, 21.7% (5 out of 23) for boys and 37.5% (15 out of 40) for girls. Overweight and obesity in these phenylketonuria patients was statistically significantly more frequent when compared to national reference studies (p = 0.0031). The five-year index of dietary control and the percentage of spikes exceeding 6 and 12 mg/dl (Spikes 6 and 12) indicated better metabolic control in the case of normal weight children than those who were overweight and obese (p < 0.049, p < 0.041 and p < 0.011, respectively). The odds ratio of being overweight or obese for those having poorer metabolic control (values higher vs lower than mean) was statistically significantly higher than for the remaining patients (for Spikes 12: 6.926 < 95%CI: 2.011-23.854 > ; p < 0.002). These results strongly suggest a link between overweight and diet non-compliance.
CONCLUSIONS: Children with classical phenylketonuria presented higher odds of being overweight or obese as compared with reference national studies, with girls only having a higher frequency of overweight.
Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Body mass index; Dietary compliance; Low phenylalanine diet; Obesity; Phenylalanine

Mesh:

Substances:

Year:  2019        PMID: 31473582     DOI: 10.1016/j.advms.2019.08.001

Source DB:  PubMed          Journal:  Adv Med Sci        ISSN: 1896-1126            Impact factor:   3.287


  4 in total

1.  Phenylketonuria Patients' and Their Caregivers' Perception of the Pandemic Lockdown: The Results of a National Online Survey.

Authors:  Dariusz Walkowiak; Bożena Mikołuć; Renata Mozrzymas; Łukasz Kałużny; Bożena Didycz; Dorota Korycińska-Chaaban; Michał Patalan; Joanna Jagłowska; Agnieszka Chrobot; Rafał Staszewski; Jarosław Walkowiak
Journal:  Children (Basel)       Date:  2022-01-19

2.  The Impact of the COVID-19 Pandemic on the Perception of Health and Treatment-Related Issues among Patients with Phenylketonuria in Poland-The Results of a National Online Survey.

Authors:  Dariusz Walkowiak; Bożena Mikołuć; Renata Mozrzymas; Łukasz Kałużny; Bożena Didycz; Dorota Korycińska-Chaaban; Michał Patalan; Joanna Jagłowska; Agnieszka Chrobot; Ewa Starostecka; Joanna Zarębska; Jarosław Walkowiak
Journal:  Int J Environ Res Public Health       Date:  2021-06-13       Impact factor: 3.390

3.  The Impact of the First 2020 COVID-19 Lockdown on the Metabolic Control of Patients with Phenylketonuria.

Authors:  Dariusz Walkowiak; Bożena Mikołuć; Renata Mozrzymas; Łukasz Kałużny; Bożena Didycz; Joanna Jaglowska; Danuta Kurylak; Jarosław Walkowiak
Journal:  Nutrients       Date:  2021-06-12       Impact factor: 5.717

4.  Overweight/obesity in adolescents with phenylketonuria: protective and predisposing factors.

Authors:  Adriana Márcia Silveira; Poliane Lopes Lima; Michelle Rosa Andrade Alves; Rosângelis Del Lama Soares; Viviane de Cássia Kanufre; Valéria de Melo Rodrigues; Ana Lúcia Pimenta Starling; Rocksane de Carvalho Norton; Marcos José Burle de Aguiar
Journal:  J Pediatr (Rio J)       Date:  2021-06-16       Impact factor: 2.990

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.